162 related articles for article (PubMed ID: 23712847)
1. Structurally diversified heterocycles and related privileged scaffolds as potential urease inhibitors: a brief overview.
Ibrar A; Khan I; Abbas N
Arch Pharm (Weinheim); 2013 Jun; 346(6):423-46. PubMed ID: 23712847
[TBL] [Abstract][Full Text] [Related]
2. Robust therapeutic potential of carbazole-triazine hybrids as a new class of urease inhibitors: A distinctive combination of nitrogen-containing heterocycles.
Ibrar A; Kazmi M; Khan A; Halim SA; Saeed A; Mehsud S; Al-Harrasi A; Khan I
Bioorg Chem; 2020 Jan; 95():103479. PubMed ID: 31901517
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, molecular docking studies and in vitro screening of ethyl 4-(3-benzoylthioureido) benzoates as urease inhibitors.
Saeed A; Khan MS; Rafique H; Shahid M; Iqbal J
Bioorg Chem; 2014 Feb; 52():1-7. PubMed ID: 24269986
[TBL] [Abstract][Full Text] [Related]
4. Ureases as a target for the treatment of gastric and urinary infections.
Follmer C
J Clin Pathol; 2010 May; 63(5):424-30. PubMed ID: 20418234
[TBL] [Abstract][Full Text] [Related]
5. Cysteine based novel noncompetitive inhibitors of urease(s)--distinctive inhibition susceptibility of microbial and plant ureases.
Amtul Z; Kausar N; Follmer C; Rozmahel RF; Atta-Ur-Rahman ; Kazmi SA; Shekhani MS; Eriksen JL; Khan KM; Choudhary MI
Bioorg Med Chem; 2006 Oct; 14(19):6737-44. PubMed ID: 16859909
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and biological evaluation of phosphoramide derivatives as urease inhibitors.
Domínguez MJ; Sanmartín C; Font M; Palop JA; San Francisco S; Urrutia O; Houdusse F; García-Mina J
J Agric Food Chem; 2008 May; 56(10):3721-31. PubMed ID: 18452297
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of novel N-(1,3-thiazol-2-yl)benzamide clubbed oxadiazole scaffolds: Urease inhibition, Lipinski rule and molecular docking analyses.
Athar Abbasi M; Raza H; Aziz-Ur-Rehman ; Zahra Siddiqui S; Adnan Ali Shah S; Hassan M; Seo SY
Bioorg Chem; 2019 Mar; 83():63-75. PubMed ID: 30342387
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of
Iqbal S; Khan A; Nazir R; Kiran S; Perveen S; Khan KM; Choudhary MI
Med Chem; 2020; 16(2):244-255. PubMed ID: 30987574
[TBL] [Abstract][Full Text] [Related]
9. Potent covalent inhibitors of bacterial urease identified by activity-reactivity profiling.
Macegoniuk K; Kowalczyk R; Rudzińska A; Psurski M; Wietrzyk J; Berlicki Ł
Bioorg Med Chem Lett; 2017 Mar; 27(6):1346-1350. PubMed ID: 28236590
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of novel competitive inhibitors of urease enzymes by a focused library of oxadiazoles/thiadiazoles and triazoles.
Amtul Z; Rasheed M; Choudhary MI; Supino R; Khan KM; Atta-Ur-Rahman
Biochem Biophys Res Commun; 2004 Jul; 319(3):1053-63. PubMed ID: 15184088
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and structure-activity relationship of thiobarbituric acid derivatives as potent inhibitors of urease.
Khan KM; Rahim F; Khan A; Shabeer M; Hussain S; Rehman W; Taha M; Khan M; Perveen S; Choudhary MI
Bioorg Med Chem; 2014 Aug; 22(15):4119-23. PubMed ID: 24986232
[TBL] [Abstract][Full Text] [Related]
12. Plant-Derived Urease Inhibitors as Alternative Chemotherapeutic Agents.
Hassan ST; Žemlička M
Arch Pharm (Weinheim); 2016 Jul; 349(7):507-22. PubMed ID: 27244041
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, biological assay in vitro and molecular docking studies of new Schiff base derivatives as potential urease inhibitors.
Aslam MA; Mahmood SU; Shahid M; Saeed A; Iqbal J
Eur J Med Chem; 2011 Nov; 46(11):5473-9. PubMed ID: 21981981
[TBL] [Abstract][Full Text] [Related]
14. The synthesis, structure and activity evaluation of pyrogallol and catechol derivatives as Helicobacter pylori urease inhibitors.
Xiao ZP; Ma TW; Fu WC; Peng XC; Zhang AH; Zhu HL
Eur J Med Chem; 2010 Nov; 45(11):5064-70. PubMed ID: 20801557
[TBL] [Abstract][Full Text] [Related]
15. Biological activity of 3-formylchromones and related compounds.
Kawase M; Tanaka T; Kan H; Tani S; Nakashima H; Sakagami H
In Vivo; 2007; 21(5):829-34. PubMed ID: 18019419
[TBL] [Abstract][Full Text] [Related]
16. A patent update on therapeutic applications of urease inhibitors (2012-2018).
Hameed A; Al-Rashida M; Uroos M; Qazi SU; Naz S; Ishtiaq M; Khan KM
Expert Opin Ther Pat; 2019 Mar; 29(3):181-189. PubMed ID: 30776929
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, in vitro Evaluation and docking studies on dihydropyrimidine-based urease inhibitors.
Iftikhar F; Ali Y; Ahmad Kiani F; Fahad Hassan S; Fatima T; Khan A; Niaz B; Hassan A; Latif Ansari F; Rashid U
Bioorg Chem; 2017 Oct; 74():53-65. PubMed ID: 28753459
[TBL] [Abstract][Full Text] [Related]
18. Lead Molecules for Targeted Urease Inhibition: An Updated Review from 2010 -2018.
Kataria R; Khatkar A
Curr Protein Pept Sci; 2019; 20(12):1158-1188. PubMed ID: 30894105
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, structures and urease inhibition studies of Schiff base metal complexes derived from 3,5-dibromosalicylaldehyde.
Cui Y; Dong X; Li Y; Li Z; Chen W
Eur J Med Chem; 2012 Dec; 58():323-31. PubMed ID: 23142672
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of 5,6-fused heterocyclic amides as Raf kinase inhibitors.
Ramurthy S; Aikawa M; Amiri P; Costales A; Hashash A; Jansen JM; Lin S; Ma S; Renhowe PA; Shafer CM; Subramanian S; Sung L; Verhagen J
Bioorg Med Chem Lett; 2011 Jun; 21(11):3286-9. PubMed ID: 21543226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
